Delivery Order SPE2DB20D3104-SPE2DB24FV9G0

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,322.80 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML intravenous infusion bottles (100 mL). The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,422.00 Firm Fixed Price Delivery Order is for the supply of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product. The contract has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,057.95 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML infusion bottles of 500ML. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, which runs through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.80 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,906.49 firm-fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product, with an ultimate completion date of December 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,197.84 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product, with a period of performance through October 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,984.20 firm fixed-price delivery order is for the supply of Omnipaque 350 mg/ml infusion bottles, a radiopaque contrast agent used in medical imaging procedures. The contract has a completion date of July 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,769.38 firm fixed-price delivery order is for the supply of OMNIPAQUE 300 MG/ML PLUSPAK 500ML, a pharmaceutical product, with a period of performance through October 2024. This contract is not designated as a set-aside and represents an open competition award. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,134.59 firm-fixed-price delivery order is for the supply of Omnipaque 300 mg/ml infusion bottles, a critical medical supply. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical for delivering a comprehensive range of pharmaceutical and...
This federal contract award, with a value of $1,726.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product. The contract has a period of performance through June 25, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation, indicating the contract was competed openly....
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV9G0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,924.05 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML infusion bottles of 100 ML. The award does not have a set-aside designation, indicating open competition.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 12:23 PM